ロード中...
FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS
Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Stolichnaya Izdatelskaya Kompaniya
2016-01-01
|
| シリーズ: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| 主題: | |
| オンライン･アクセス: | https://www.rpcardio.com/jour/article/view/1052 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|